NRG4, as an adipose endocrine factor, could inhibit the expansion of macrophages with tumor-associated macrophage molecular characteristics and inhibit the depletion of CD8+ T cells caused by tumor-associated macrophages, thereby exerting anti-hepatocellular carcinoma effects (58). The gene discussed is CD8A; the disease is neoplasm.